Fiocruz the National Contact Point in Health
|
|
|
- Annabelle Richard
- 5 years ago
- Views:
Transcription
1 Fiocruz the National Contact Point in Health
2 Fundação Oswaldo Cruz FIOCRUZ Research Education Innovation and Production Surveillance and Reference Services Health & Medical Care Environment and Health Promotion Information and Communication History of Science and Health Planning and Management
3 FIOCRUZ IN BRASIL Present in 11 states with 16 Institutes and 4 new regional offices. 800 thousand m² of built area - Campus Manguinhos, RJ. Fonte: Coordenadoria de Comunicação Social/Fiocruz States with Fiocruz Institutes Location of the new offices
4 FIOCRUZ Strengthening of National Health Systems. Horizontal cooperation in training, research and products for health. OECD, BRICS, Latin America, CPLP (Africa e Asia) and other African countries. Acting in the Health International Networks: National Health Institutes; National Public Health Schools; Health Technical Schools; Pan- Amazon Network of ST&I in Health. Ø Document of Health for the Post-2015 Sustainable Development Agenda. Ø Plant of antiretroviral and other drugs (Mozambique) Ø Strengthen of the health systems of Angola and Haiti. Ø Participate in the creation of the South-American Institute of Government in Health (Isags-Unasul). Ø Cooperation in the field of neurosciences with French Institutes.
5 International Cooperation Technical cooperation CPLP DNDI IBSA BRICS Pasteur Network (RIIP)
6 INTERNATIONAL REFERENCE CENTERS Fiocruz - Who Collaborating Center Global Health South- South cooperation. Influenza pre-candidate. Leptospirosis. Pharmaceutical Policies. Environmental and Public Health. Education of Health Technicians. Childhood Blindness. Other References Diagnostic & molecular typing Human retroviruses Control of Schistosomiasis Typing of Leishmaniasis Measles & other exanthematous viral infections Polio & other enterovirus infection Malaria Epidemiology of Congenital malformations
7 HEALTH & MEDICAL CARE - REFERENCE CENTERS INFECTIOUS DISEASES Leishmaniasis, Mycoses, Tuberculosis and other mycobacteria Sexually Transmitted Diseases and HIV-AIDS Dengue and other acute Fevers MATERNAL & INFANT CARE High risk pregnancy, Neonatology, Genetic counseling, Pediatrics, Lactation and human milk banks Cervical and uterine cancers HEALTH CENTER - PRIMARY CARE Health promotion protocols (seniors, AIDS, drug addiction) Prenatal care Immunization program Clinical trials
8 PRODUCTION Immunobiological Technology Institute (Bio-Manguinhos) vaccines, biopharmaceuticals, IVD reagentes. Foto Genilson Araújo Institute of Pharmaceutical Technology (Farmanguinhos) Some products: anti-infectious medicines, painkillers, medicines for endemic diseases (malaria and tuberculosis), antiretroviral drugs against AIDS. Carlos Chagas Institute (ICC/Fiocruz Parana) Development of studies on molecular biology, functional genomics (including bioinformatics) and cellular biology.
9 SOUTH-SOUTH COOPERATION International Networks (CPLP and UNASUL) National Institutes of Health - RINS National Schools of Public Health - RESP Health Technical Schools - RETS Human Milk Bank - RBLH Master - PHD Angola (Public Health) Peru (Public Health) Argentina (Cellular and Molecular Biology) Argentina (Epidemiology in Public Health) Mozambique (Cellular and Molecular Biology and Tropical Medicine)
10 CONTRIBUTION TO INTERNATIONAL PUBLIC HEALTH 74 COUNTRIES Vaccines: Yellow Fever vaccine and Meningococcal AC/ : 168,119,180 doses Central America, North America and Caribbean 24 countries African 28 countries Asia 10 countries South America 11 countries Oceania 1 country
11
12 Stratified host-directed approaches to improve prevention, treatment and/or cure of infectious diseases Translational collaborative cancer research between Europe and the Community of Latin American and Caribbean States (CELAC) Implementation of research for maternal and child health Research on HIV, tuberculosis (TB) and or hepatitis C (HCV)in patients with mono-co-infections and/or comorbidities in the context of foresting collaboration with researchers with the Russian Federation.
13 Establishment of an International Network of Social Sciences Research Centers to help address governance and of the challenges in the preparedness for and the response to infectious threats Creation of a European wide sustainable clinical research network for infectious diseases
14 Bioeconomics, Food security, Sustainable agriculture, OPPORTUNITIES Technological development especially in the fields: Neglected diseases, Chronic noncommunicable diseases, Energy, Nanotechnology, Marine research. Neurological disorders, Metabolic diseases, Omics techonology
15 NATIONAL INSTITUTES OF SCIENCE AND TECHNOLOGY - INCT
16
17
18
19
20
21
22 DATABASE ON BAZILIAN RESEARCHERS - Information on areas of activities - Publications - Collaborations
23
24 THANK YOU Rodrigo Correa-Oliveira, Ph.D. Vice-presidente of Research and Biological Collections
A Project of the International Technical Cooperation between Brazil and Mozambique in Health
A Project of the International Technical Cooperation between Brazil and Mozambique in Health Initiative for Antiretrovirals and Additional Drugs Factory Plant Installation in Mozambique Consultative Workshop
On behalf of the Infectious Diseases Society of America (IDSA), I offer testimony in
Testimony of the Infectious Diseases Society of America (IDSA) on the Fiscal Year 2018 Department of Health and Human Services Budget Prepared for the U.S. House of Representatives Subcommittee on Labor-HHS-Education
Laboratory Services and Networks Your priorities?
12th Meeting Caribbean National Epidemiologists and Laboratory Directors September 17th-19th, 2014 POS, Trinidad and Tobago Laboratory Services and Networks Your priorities? Dr Cristina Gutierrez Laboratory
RUSSIA Mobilizing support for the Global Fund to Fight AIDS, Tuberculosis, and Malaria
RUSSIA 3.1 HEALTH FINANCING AND STRENGTHENING HEALTH SYSTEMS 3.1.1 We will continue our efforts towards the goal of providing at least a projected US$ 60 billion to fight infectious diseases and improve
Latest Funding Trends in AIDS Response
Latest Funding Trends in AIDS Response 20 th International AIDS Conference Melbourne, Australia J.V.R. Prasada Rao United Nations Secretary-General s Special Envoy for AIDS in Asia and the Pacific 21 July
A UNIQUE NETWORK OF EXPERTISE DEDICATED TO THE FIGHT AGAINST INFECTIOUS DISEASES
A UNIQUE NETWORK OF EXPERTISE DEDICATED TO THE FIGHT AGAINST INFECTIOUS DISEASES Since 1888, date of its creation, has been committed to contain infectious diseases by working directly in regions where
The Unfinished Agenda in Global Health. Richard Skolnik
The Unfinished Agenda in Global Health Richard Skolnik Objectives Objectives: What do poor people in poor countries get sick and die from? What are the risk factors for this burden of disease? What can
Center for Global Health. CDC Global Health Saving Lives Overseas, Protecting Americans at Home
Center for Global Health CDC Global Health Saving Lives Overseas, Protecting Americans at Home CDC Overview Part of the U.S. Department of Health and Human Services, CDC is the nation s leading public
Collaborations in more than 50 countries. 400 scientific papers published every year. Over 800 professionals trained every year
Antoni Plasència General Director In an interdependent world, health is a global issue. Our commitment to improving the health of all people and ensuring greater equity is implemented through the generation,
56th DIRECTING COUNCIL
56th DIRECTING COUNCIL 70th SESSION OF THE REGIONAL COMMITTEE OF WHO FOR THE AMERICAS Washington, D.C., USA, 23-27 September 2018 Agenda Item 2.5 23 September 2018 Original: English AGENDA 1. Opening of
Polio Transition Planning: Risks and opportunities of transitioning resources to non-polio public health interventions
Polio Transition Planning: Risks and opportunities of transitioning resources to non-polio public health interventions Global Polio Partners Group (PPG) meeting June 26, 2017 Underlying premise: Transition
Product Development for Vaccines Advisory Committee:
Product Development for Vaccines Advisory Committee: Highlights from the 2016 year of vaccine development SAGE, October 2016 David C. Kaslow, MD Chair, Product Development for Vaccines Advisory Committee
66th Annual meeting of the American Society of Tropical Medicine and Hygiene Baltimore, USA
66th Annual meeting of the American Society of Tropical Medicine and Hygiene Baltimore, USA 5 9 November 2017 EDCTP Wellcome Trust symposium on Challenges and opportunities of conducting clinical trials
~Health and Development Initiative~
~Health and Development Initiative~ Global Issues Division International Cooperation Bureau Ministry of Foreign Affairs, Japan March 2007 More than 10 million children
Chagas Initiative. Chagas disease is one of the main public health problems in Latin America, where it is more common than malaria
Chagas Initiative Chagas Initiative The Chagas Initiative aims to increase access to effective diagnosis and treatment for patients with Chagas disease, both in endemic and non-endemic countries, and to
Japan Agency for Research and Development (AMED); Its Missions and Challenges
Japan Agency for Research and Development (AMED); Its Missions and Challenges December 8 th, 2017 Masahiko NODA Managing Director Department of International Affairs Japan Agency for Medical Research and
Introduction. Infections acquired by travellers
Introduction The number of Australians who travel overseas has increased steadily over recent years and now between 3.5 and 4.5 million exits are made annually. Although many of these trips are to countries
MEETING OF INTERESTED PARTIES
WORLD HEALTH ORGANIZATION MEETING OF INTERESTED PARTIES GENEVA, 3 TO 7 NOVEMBER 2003 Timetable and annotated agenda Please note that the timetable is indicative and that the timing of discussions may vary
Government of Canada Federal AIDS Initiative Milestones
HIV in Canada: Trends and Issues for Advancing Prevention, Care, Treatment and Support Through Knowledge Exchange Michael R Smith, Senior Policy Advisor, Programs and Coordination Division, Centre for
Good Health & Well-Being. By Alexandra Russo
Good Health & Well-Being By Alexandra Russo SDG 3 Goal 3 aims to ensure healthy living and promote well-being for all at all ages There are 9 targets associated with SDG 3 The targets encompass a wide
Overall presentation of IVR Strategy
Annex 3 Overall presentation of IVR Strategy Presentation to the IVR Advisory committee (IVAC) April 2007 Outline Why does WHO invest in Research & Development? What is the Initiative for Vaccine Research
Global Consultation on Child and Adolescent Health and Development 13 March 2002 Stockholm, Sweden
Global Consultation on Child and Adolescent Health and Development 12-13 13 March 2002 Stockholm, Sweden Mdm. Bruntland Says: 11 million children die each year 8 million can be averted each year Each decade
Economics of Vaccine Development A Vaccine Manufacturer s Perspective
Economics of Vaccine Development A Vaccine Manufacturer s Perspective Gerald Voss The Value of Vaccines 2 29 diseases are currently preventable by vaccination Global public health Cervical cancer 1 Diphtheria
Sustaining Immunization in Developing Countries: The Future We Make
Sustaining Immunization in Developing Countries: The Future We Make Global Health Summit Denver, CO 29 April 211 Jon Kim Andrus, MD Deputy Director Umbrella of protection in the Americas Measles eradication
Version for the Silent Procedure 29 April Agenda item January Hepatitis
Version for the Silent Procedure 29 April 2014 134th session EB134.R18 Agenda item 10.5 25 January 2014 Hepatitis The Executive Board, Having considered the report on hepatitis, 1 RECOMMENDS to the Sixty-seventh
Public Health Image Library. CDC/ Cynthia Goldsmith. Image #
Zika Virus Fredrick M. Abrahamian, D.O., FACEP, FIDSA Clinical Professor of Medicine UCLA School of Medicine Director of Education Department of Emergency Medicine Olive View-UCLA Medical Center Sylmar,
DEPARTMENT OF DEFENSE AFHSB Reportable Events Monthly Report
DEPARTMENT OF DEFENSE AFHSB Reportable Events Monthly Report July 2016 Report Description Reportable Events among all beneficiaries received from the Services over the past 5 years are used to create ranges
DEPARTMENT OF DEFENSE AFHSB Reportable Events Monthly Report
DEPARTMENT OF DEFENSE AFHSB Reportable Events Monthly Report May 2016 Report Description Reportable Events among all beneficiaries received from the Services over the past 5 years are used to create ranges
. /////////////////// /////////////////// / Berenice? . BLOOD HEPATITIS B HEPATITIS C HIV T. pallidum T. cruzi TRANSFUSION HOST The Southern Cone Initiative, 1991 The Ministers of Health of Argentina,
WHO Global Health Sector Strategies HIV; Viral Hepatitis; Sexually Transmitted Infections
Common structure Universal Health Coverage SDGs Cascade of services Vision, Goals and Targets Costed Actions WHO Global Health Sector Strategies 2016-2021 HIV; Viral Hepatitis; Sexually Transmitted Infections
Background. Proposed to develop a framework for action. Address by Foreign Minister Koumura
July 2008 Ministry of Foreign Affairs of Japan Background Address by Foreign Minister Koumura Global Health and Japan s Foreign Policy From Okinawa to Toyako (25 November 2007) Special Address by Prime
Okinawa, Toyako, and Beyond: Progress on Health and Development
Okinawa, Toyako, and Beyond: Progress on Health and Development Prof. Michel D. Kazatchkine Executive Director The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations University, Tokyo,
Progress on the targets of Millennium Development Goal 6 in central and eastern Europe and central Asia
Progress on the targets of Millennium Development Goal 6 in central and eastern Europe and central Asia 11 October 2011 Moscow, Russian Federation Zsuzsanna Jakab WHO Regional Director for Europe Millennium
Disease Prevention, Detection & Response During Public Health Emergencies
Centers for Disease Control and Prevention Disease Prevention, Detection & Response During Public Health Emergencies Tom Frieden, MD, MPH Director, Centers for Disease Control and Prevention Global Disaster
CIDRAP Leadership Forum Infectious Disease BRIEFING
Center for Infectious Disease Research and Policy University of Minnesota CIDRAP Leadership Forum Infectious Disease BRIEFING December 13 th, 2017 CLF BRIEFING HOT TOPICS 1. Influenza (surveillance, vaccine,
The Current Status of the Epidemiologic Transition
The Current Status of the Epidemiologic Transition There are still job opportunities in Infectious Diseases and Tropical Medicine CAPT John W. Sanders, Medical Corps, US Navy Commanding Officer, Naval
52 Young people take advantage of low tide to play football on tidal flats in New Caledonia. Report of the Regional Director
52 Young people take advantage of low tide to play football on tidal flats in New Caledonia. Report of the Regional Director Pacific Technical Support Introduction 1. Pacific Health Ministers Meeting and
Sanofi Pasteur: A partner in eradicating vaccine preventable diseases and improving access to vaccines
Sanofi Pasteur: A partner in eradicating vaccine preventable diseases and improving access to vaccines 1 Vaccines: the single most effective medical intervention 2 Vaccines save lives Millions of cases
Yellow fever. Key facts
From: http://www.who.int/en/news-room/fact-sheets/detail/yellow-fever WHO/E. Soteras Jalil Yellow fever 14 March 2018 Key facts Yellow fever is an acute viral haemorrhagic disease transmitted by infected
Antimicrobial resistance Fact sheet N 194 Updated April 2014
Antimicrobial resistance Fact sheet N 194 Updated April 2014 Key facts Antimicrobial resistance (AMR) threatens the effective prevention and treatment of an ever-increasing range of infections caused by
Our Mission. To promote healthy and safe travel by providing medicines, preventive vaccines and health counseling to a diverse group of travelers
Our Mission To promote healthy and safe travel by providing medicines, preventive vaccines and health counseling to a diverse group of travelers The Travel Clinic utilizes national and international travel
ENDING AIDS, TB AND MALARIA AS EPIDEMICS
ENDING AIDS, TB AND MALARIA AS EPIDEMICS A SMART INVESTMENT In 2000, AIDS, tuberculosis and malaria appeared to be unstoppable. In many countries, AIDS devastated an entire generation, leaving countless
Introduction to Global Child Health Elective for Pediatric Residents and Fellows Children s National Medical Center, Washington, DC.
Introduction to Global Child Health Elective for Pediatric Residents and Fellows Children s National Medical Center, Washington, DC October 11-15, 2010 Pre-Course Test 1. You are preparing for an elective
Corporate Presentation
Corporate Presentation January 2019 2018 Chembio. All Rights Reserved. # 2019 Chembio. All Rights Reserved. Page 1 Safe Harbor Statement Statements contained herein that are not historical facts are forward-looking
Below you will find information about diseases, the risk of contagion, and preventive vaccinations.
Vaccinations Below you will find information about diseases, the risk of contagion, and preventive vaccinations. DTP - Diphtheria Tetanus Polio Yellow fever Hepatitis A Typhoid fever Cerebrospinal meningitis
AGENDA Tropical Medicine Course Monday October 24 - Friday November 4, 2011
AGENDA Tropical Medicine Course Monday October 24 - Friday November 4, 2011 Monday October 24, Day 1 Mt Oxford Auditorium, Children s Hospital Colorado 8:00-8:20 Registration 8:20-8:30 Overview of the
CIDRAP Leadership Forum Infectious Disease BRIEFING August 17, 2016
Center for Infectious Disease Research and Policy University of Minnesota CIDRAP Leadership Forum Infectious Disease BRIEFING August 17, 2016 CLF BRIEFING 1. Vectorborne diseases Zika Yellow Fever, Chikungunya,
Why do we need SD goals on climate change, environment and health
Why do we need SD goals on climate change, environment and health Roberto Bertollini, M.D, MPH Chief Scientist and WHO Representative to the EU World Health Organization Joint DEVE-ENVI public hearing
11 Indicators on Thai Health and the Sustainable Development Goals
11 11 Indicators on Thai Health and the Sustainable Development Goals 11 Indicators on Thai Health and the Sustainable Development Goals The Post -2015 Development Agenda began upon completion of the monitoring
Adolescent vaccination strategies
Adolescent vaccination strategies Gregory Hussey Vaccines for Africa Initiative Institute of Infectious Diseases & Molecular Medicine University of Cape Town www.vacfa.uct.ac.za gregory.hussey@uct.ac.za
Since the start t of the HIV/ 1980 s: 77.3 million people have be. In million people were liv
The HIV/AIDS Epidemic and Sustainable Development tgoals Etienne Karita, MD MSc MSPH Kigali, 8 Nov 018 IV/AIDS Burden Since the start t of the HIV/ V/AIDS epidemic i in the early 1980 s: 77.3 million people
FAST-TRACK COMMITMENTS TO END AIDS BY 2030
FAST-TRACK COMMITMENTS TO END AIDS BY 2030 FAST-TRACK COMMITMENTS TO END AIDS BY 2030 90-90-90 1 Ensure that 30 million people living with HIV have access to treatment through meeting the 90 90 90 targets
GLOBAL HEALTH SPESIALISERING IN. Austen Davis
GLOBAL HEALTH SPESIALISERING IN SAMFUNNSMEDISIN 16.02.2016 Austen Davis SUSTAINABLE DEVELOPMENT GOALS THE POST 2015 AGENDA Where do we come from? 14 th C quarantine Tropical Health International Health
Program to control HIV/AIDS
90-90-90 Program to control HIV/AIDS Hamid Sharifi Associate Professor in Epidemiology [sharifihami@gmail.com] 1 Targets for ending the AIDS epidemic 2 New HIV infections in low- and middle-income countries,
Fact sheet. Yellow fever
Fact sheet Key facts is an acute viral haemorrhagic disease transmitted by infected mosquitoes. The yellow in the name refers to the jaundice that affects some patients. Up to 50% of severely affected
HIV/AIDS in East Asia
HIV/AIDS in East Asia Yonsei University Graduate School of Global Health Sohn, Myong Sei Epidemiology Global summary of the AIDS epidemic, 2008 Number of people living with HIV in 2008 Total Adults Women
AIDS at 25. Epidemiology and Clinical Management MID 37
AIDS at 25 Epidemiology and Clinical Management Blood HIV Transmission transfusion injection drug use Sexual Intercourse heterosexual male to male Perinatal intrapartum breast feeding Regional HIV and
Trends in HIV/AIDS epidemic in Asia, and its challenge. Taro Yamamoto Institute of Tropical Medicine Nagasaki University
Trends in HIV/AIDS epidemic in Asia, and its challenge Taro Yamamoto Institute of Tropical Medicine Nagasaki University Millennium Development Goals Goal 1. Eradicate extreme poverty and hunger Goal 2.
Science and Technology Research Partnership for Sustainable Development (SATREPS)
1 Science and Technology Research Partnership for Sustainable Development () Kaname KANAI, M.D., Ph.D Executive Technical Advisor, Human Development Deaprtment Japan International Cooperation Agency JICA
Malaria in pregnancy programmes: challenges and priorities in antimalarial drug development for African pregnant women
7 th MIM Pan African Malaria Conference 15-20 April 2018 Dakar, Senegal The power of sharing science EDCTP session on Malaria in pregnancy programmes: challenges and priorities in antimalarial drug development
Health Security in Southeast Asia
Health Security in Southeast Asia J. Kevin Baird, Ph.D. P.T. Hygienica Jakarta Health Risks & Security What is health security? Awareness of possible threats Monitoring likely threats Minimizing likely
Neglecting Diseases. Jason Silverstein Department of Anthropology Harvard University
Neglecting Diseases Jason Silverstein Department of Anthropology Harvard University I will give you a talisman. Whenever you are in doubt or when the self becomes too much with you, apply the following
Viral Hepatitis B and C in North African Countries
Viral Hepatitis B and C in North African Countries Prevalence, Risk factors and How to prevent Prof. Ossama Rasslan President, ESIC ICAN, Vice-Chair ICAN 2014, Harare, Zimbabwe, Nov 3rd 5th Overview Viral
Global Governance for Health: Protecting Vulnerable People from Infectious Diseases in Countries with Weak Health System
2016 Australasian Aid Conference Global Governance for Health: Protecting Vulnerable People from Infectious Diseases in Countries with Weak Health System Yasushi KATSUMA, Ph.D. Dean & Professor, Graduate
CHOLERA UPDATES in Indonesia
CHOLERA UPDATES in Indonesia Musal Kadim MD Gastrohepatology Division, Child Health Department, University of Indonesia Indonesian Pediatric Society Cholera epidemiology update History 7 cholera pandemics
United States House of Representatives. I am the Executive Director of the North America office
Rachel M. Cohen, Executive Director Drugs for Neglected Diseases initiative, North America Written Testimony, Outside Witness Hearing Subcommittee on State and Foreign Operations, Committee on Appropriations
General Description. Significance
General Description The Zika virus is a member of the Flavivirus family, and is a small, enveloped virus (easy to kill with a hospital disinfectant). Zika virus is an emerging mosquito-borne virus that
Zika Virus What Every Woman Needs to Know
Zika Virus What Every Woman Needs to Know Carrie L. Byington, MD The Jean and Thomas McMullin Professor and Dean of Medicine Senior Vice President Health Science Center Vice Chancellor for Health Services
CAPACITY BUILDING TRAINING WORKSHOP ON VIRAL HEPATITIS FOR AFRICAN UNION MEMBER STATES. Cairo, Egypt
المؤسسة اإلفريقية لمرضي الكبد African Liver Patients Association L Association Africaine des Patients atteints d Hépatite Virale CAPACITY BUILDING TRAINING WORKSHOP ON VIRAL HEPATITIS FOR AFRICAN UNION
Infectious Disease Hot Topics: 2008
Infectious Disease Hot Topics: 2008 Joseph Domachowske MD Professor of Pediatrics, Microbiology and Immunology Golisano Children s Hospital at SUNY Upstate Medical University Topic 1: COMMUNITY-ASSOCIATED
Global health sector strategies on HIV, viral hepatitis and sexually transmitted infections ( )
Regional Committee for Europe 65th session EUR/RC65/Inf.Doc./3 Vilnius, Lithuania, 14 17 September 2015 2 September 2015 150680 Provisional agenda item 3 ORIGINAL: ENGLISH Global health sector strategies
Priority Medicines for Europe and the World: Setting a public health based medicines development agenda
Priority Medicines for Europe and the World: Setting a public health based medicines development agenda Warren Kaplan, Veronika Wirtz (BU School of Public Health) Aukje Mantel, Pieter Stolk (UU) Béatrice
Concept note. 1. Background and rationale
Concept note Inter-Country Workshops for Strengthening Regional and National Human Capacity to Accelerate Scaling up of National PMTCT and Paediatric Care, Support and Treatment Programmes TOWARDS UNIVERSAL
Fondation Mérieux Mission and Activities
Fondation Mérieux Mission and Activities Testes de Diagnóstico in Vitro Acessíveis e com Qualidade Assegurada para Programas de Saúde Pública Brazil April 2012 JF de Lavison MISSION Strengthen local capacities
Thank you for the opportunity to submit testimony on the Fiscal Year (FY) 2014 State
Drugs for Neglected Diseases initiative, North America Jennifer Katz, Policy Director March 2013 Testimony to the Subcommittee on State and Foreign Operations, Committee on Appropriations United States
Accelerating progress towards the health-related Millennium Development Goals
Accelerating progress towards the health-related Millennium Development Goals The critical role of the national health policy & strategy in strengthening health systems and delivering effective interventions
Working for an International Organization in Public-Private Partnership : The Global Fund to Fight AIDS, Tuberculosis and Malaria
Working for an International Organization in Public-Private Partnership : The Global Fund to Fight AIDS, Tuberculosis and Malaria Birgit Poniatowski Acting Manager, Board Relations Overview The Global
The new German strategy on HIV, Hepatitis B, C and STI, an integrated approach. Ines Perea Ministry of Health, Germany
The new German strategy on HIV, Hepatitis B, C and STI, an integrated approach Ines Perea Ministry of Health, Germany Reasons for a new strategy in 2016 New international agreements (SDG s) Renewed political
ENDING AIDS, TB AND MALARIA AS EPIDEMICS
ENDING AIDS, TB AND MALARIA AS EPIDEMICS A SMART INVESTMENT In 2000, AIDS, tuberculosis and malaria appeared to be unstoppable. In many countries, AIDS devastated an entire generation, leaving countless
Creating VaCCines, ProteCting Life
Creating VaCCines, ProteCting Life PreVenting Disease through VaCCination a Constant BattLe Immunization has been a great public health success story. The lives of millions of children have been saved,
AIDS at 30 Epidemiology and Clinical Epidemiology and Management MID 37
AIDS at 30 Epidemiology and Clinical Management Blood HIV Transmission transfusion injection drug use Sexual Intercourse heterosexual male to male Perinatal intrapartum breast feeding Adults and children
5 th Islamic Conference of Health Ministers. Resolution. Istanbul, Turkey November 2015 (5-7 Safar 1437H)
5 th Islamic Conference of Health Ministers Resolution Istanbul, Turkey 17-19 November 2015 (5-7 Safar 1437H) Draft Resolution No. 2/5-ICHM On Healthy Life Style, Prevention and Control of Communicable
Lessons learned from the IeDEA West Africa Collaboration
Lessons learned from the IeDEA West Africa Collaboration François DABIS with the contribution of Didier Koumavi EKOUEVI INSERM U-897, Bordeaux, France, Programme PACCI, ANRS site, Abidjan, Côte d Ivoire
The Future of Health in Africa
The Future of Health in Africa Organised by the Global Health Centre at the Graduate Institute, the Chatham House and the International Federation of Pharmaceutical Manufacturers and Associations Biographies
Monitoring the achievement of the health-related Millennium Development Goals
SIXTY-SIXTH WORLD HEALTH ASSEMBLY A66/13 Provisional agenda item 14.1 14 May 2013 Monitoring the achievement of the health-related Millennium Development Goals Report by the Secretariat 1. In response
Progress against the HIV Epidemic: is the end in sight?
Progress against the HIV Epidemic: is the end in sight? Christine Hughes, BscPharm, PharmD, FCSHP Professor, Faculty of Pharmacy & Pharmaceutical Sciences University of Alberta Clinical Pharmacist, Northern
Multiple Choice Questions
Multiple Choice Questions 1. Which one of the following is not a viral disease? (a) Dengue (b) AIDS (c) Typhoid (d) Influenza 2. Which one of the following is not a bacterial disease? (a) Cholera (b) Tuberculosis
CONTACTS & ACKNOWLEDGEMENTS
CONTACTS & ACKNOWLEDGEMENTS Snohomish Health District Communicable Disease Surveillance and Response Analysis and publication: Hollianne Bruce, MPH Program Manager: Amy Blanchard, RN, BSN Communicable
EC research and innovation strategy and actions
EC research and innovation strategy and actions for preparedness and response to outbreaks IMI Stakeholder Forum 28-29 September 2016 Line Matthiessen Head of Unit E.3 Health Directorate DG Research &
7 th FIDSSA CONFERENCE 2017 Programme as at 11 May 2017 PROVISIONAL ACADEMIC PROGRAMME
THURSDAY 9 NOVEMBER 15h00 17h00 Conference Registration FIDSSA Official Opening Ceremony 17h00 17h15 Welcome & Opening - Marc Mendelson (FIDSSA President) PLENARY SESSION 1: Emerging and Re-Emerging Infectious
Suggested Exercises and Projects 395
Suggested Exercises and Projects 395 Projects These suggested projects are taken in part from the recent book A Course in Mathematical Biology: Quantitative Modeling with Mathematical and Computational
Zika Virus and Prevention in Mississippi
Mississippi State Department of Health Mississippi Morbidity Report Volume 32, Number 1 July 2016 Background: Zika Virus and Prevention in Mississippi Key Messages: Zika virus infection during pregnancy
Maternal, Child and Reproductive Health Initiative
Maternal, Child and Reproductive Health Initiative Maternal, Child and Reproductive Health Initiative The Maternal, Child and Reproductive Health (MCRH) Initiative works in developing countries to improve
SECTOR ASSESMENT (SUMMARY): HEALTH
Greater Mekong Subregion Health Security Project RRP REG-48118-002 SECTOR ASSESMENT (SUMMARY): HEALTH A. Sector Performance, Problems, and Opportunities 1. The governments of Cambodia, the Lao PDR, Myanmar,
Program: Expanding immunization coverage for children
1 of 7 05/04/2012 20:51 Published on GiveWell (http://givewell.org) Home > Program: Expanding immunization coverage for children Program: Expanding immunization coverage for children In a nutshell The
WHO: Forum Issue #02 Student Officer Position:
WHO: Topic B Forum : World Health Organization Issue #02 : Topic B: Preparing for a Global Health Crisis Student Officer : Samantha Portillo Position: Chair of the United Nations World Health Organization
the Office of Research Application Portal: Materials to submit:
Title: PAR 17 237: Centers for AIDS Research (P30) Slots: 1 Internal Deadline: LOI: External Deadline: Award Information: Submission Process: May 26, 2018, 5pm PDT 30 days prior to the application due
Travel Medicine and Mens Health. Acurity Health GP Conference 2016 Dr Jenny Visser University of Otago, Wellington
Travel Medicine and Mens Health Acurity Health GP Conference 2016 Dr Jenny Visser University of Otago, Wellington Why Travel Medicine? Because People travel They travel to and within tropical and/or developing
CS/PoliSci/Statistics C79 Societal Risks & The Law
CS/PoliSci/Statistics C79 Societal Risks & The Law Nicholas P. Jewell Department of Statistics & School of Public Health (Biostatistics) University of California, Berkeley March 19, 2013 1 Nicholas P.
Centers for Disease Control and Prevention (CDC) Coalition C/o American Public Health Association 800 I Street NW Washington, DC,
Centers for Disease Control and Prevention (CDC) Coalition C/o American Public Health Association 800 I Street NW Washington, DC, 20001 202-777-2514 Donald Hoppert, Director of Government Relations, American